ATA® Guidelines Development

The members of the American Thyroid Association® are thyroid specialists dedicated to transforming thyroid care through clinical excellence, education, scientific discovery and advocacy in a collaborative community.

The Guidelines were compiled by American Thyroid Association® Guidelines Taskforces selected for their expertise on the topic. The Guidelines are reviewed by the ATA® Board of Directors and submitted to the ATA® membership for comment.

GUIDELINES Pocketcards

Official American Thyroid Association® Practice GUIDELINES Pocketcards quick reference-tools provide your physicians, fellows, nurses, and students with instant access to current ATA® guidelines information in a clear concise format.

Submit a Proposal for ATA Guidelines and Statements

Please login to members only:

Process for initiating a new ATA guideline or statement for peer reviewed publication

American Thyroid Association® (ATA) Guidelines and Surgical Statements

ATA Guidelines

Guidelines for Management of Patients with Anaplastic Thyroid Cancer (2021)

Thyroid Volume 31 Issue 3 March 20212021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Keith C. Bible, et al., Thyroid.Mar 2021.337-386.

Anaplastic Thyroid Cancer GUIDELINES Pocket Card



Anaplastic Thyroid Cancer GUIDELINES Pocket Card

Anaplastic Thyroid Cancer Patient Guide

Anaplastic Thyroid Cancer Patient GUIDELINE Pocket Card




Executive Summary Video
Task force Chairs Keith C. Bible, MD and Electron Kebebew, MD provide a video overview of the Guidelines for Management of Patients with Anaplastic Thyroid Cancer.

Teaching Tools
ATA Clinical Affairs Committee provide teaching tools for the use of the Management of Patients with Anaplastic Thyroid Cancer Guidelines.

Slide Sets:
Diagnosis: Cytology, Histopathology, Differential Diagnosis     Download | PDF
Initial Preoperative Evaluations and Establishing Goals of Care     Download | PDF
Surgical Management     Download | PDF
Radiotherapy and Systemic Chemotherapy in Loco-Regionally Confined Stages IVA and IVB     Download | PDF
Systemic Therapy for Unresectable ATC Stage IVB and IVC Patients & Approach to Metastases     Download | PDF


Case Based Discussion:
Targeted Therapies in ATC

Initial Diagnosis, Evaluation and Goals of Care in ATC

Surgical management and Radiotherapy for ATC


None of the information posted is intended as medical, legal, or business advice, or advice about reimbursement for health care services. The mention of any product, service, company, therapy or physician practice does not constitute an endorsement of any kind by ATA. ATA assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the material contained in, posted on, or linked to this site, or any errors or omissions.

ATA Statements

Statement on Management of Thyroid Eye Disease

Thyroid Volume 32 Issue 12Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and European Thyroid Association
Henry B. Burch, et al., THYROID Volume 32, Number 12, 2022.

An overview webinar presented by the ATA-ETA Thyroid Eye Disease Consensus Statement Taskforce

ATA Guidelines Disclaimer

The American Thyroid Association develops Clinical Practice Guidelines to provide guidance and recommendations for particular practice areas concerning thyroid disease and thyroid cancer. The Guidelines are not inclusive of all proper approaches or methods, or exclusive of others. The Guidelines do not establish a standard of care and specific outcomes are not guaranteed.

Treatment decisions must be made based on the independent judgment of health care providers and each patient’s individual circumstances. A guideline is not intended to take the place of physician judgment in diagnosing and treatment of particular patients. Read More…